Translational Development Acquisition Corp. Ordinary Shares (TDAC) Return on Equity (ROE) (2022 - 2026)

Translational Development Acquisition Corp. Ordinary Shares (TDAC) Return on Equity (ROE) from Mar 31, 2022 to Mar 31, 2026. The TTM Translational Development Acquisition Corp. Ordinary Shares (TDAC) Return on Equity (ROE) is 0.76%. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.